Precision screening for colorectal cancer: Promise and challenges

Annals of Internal Medicine

Volumn 163, Issue 5, 2015, Pages 390-391

  Doubeni, Chyke A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; CANCER PATIENT; CANCER RISK; CANCER SCREENING; CLINICAL DECISION MAKING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CROSS-SECTIONAL STUDY; EDITORIAL; FOLLOW UP; GENETIC COUNSELING; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; PRIORITY JOURNAL; SIGMOIDOSCOPY; SMOKING; WAIST CIRCUMFERENCE; COLORECTAL NEOPLASMS; FEMALE; MALE; PROCEDURES; RISK ASSESSMENT;

COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; RISK ASSESSMENT;

EID: 84940524431     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M15-1677     Document Type: Editorial

References (10)

1. Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544-73. [PMID: 19998273] doi:10.1002/cncr.24760
2. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988;319:525-32. [PMID: 2841597]
3. Zauber AG, Lansdorp-Vogelaar I, Knudsen AB, Wilschut J, van Ballegooijen M, Kuntz KM. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med. 2008;149:659-69. [PMID: 18838717] doi:10.7326/0003-4819-149-9-200811040-00244
4. Kelloff GJ, Schilsky RL, Alberts DS, Day RW, Guyton KZ, Pearce HL, et al. Colorectal adenomas: a prototype for the use of surrogate end points in the development of cancer prevention drugs. Clin Cancer Res. 2004;10:3908-18. [PMID: 15173100]
5. Fedewa SA, Goodman M, Flanders WD, Han X, Smith RA, M Ward E, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer. 2015. [PMID: 26042576] doi:10.1002/cncr.29494
6. Schully SD, Carrick DM, Mechanic LE, Srivastava S, Anderson GL, Baron JA, et al. Leveraging biospecimen resources for discovery or validation of markers for early cancer detection. J Natl Cancer Inst. 2015;107. [PMID: 25688116] doi:10.1093/jnci/djv012
7. Mai PL, Wentzensen N, Greene MH. Challenges related to developing serum-based biomarkers for early ovarian cancer detection. Cancer Prev Res (Phila). 2011;4:303-6. [PMID: 21372029] doi:10.1158/1940-6207.CAPR-11-0053
8. Imperiale TF, Monahan PO, Stump TE, Glowinski EA, Ransohoff DF. Derivation and validation of a scoring system to stratify risk for advanced colorectal neoplasia in asymptomatic adults. A crosssectional study. Ann Intern Med. 2015;163:339-46. doi:10.7326/M14-1720
9. Shaukat A, Church TR, Shanley R, Kauff ND, O'Brien MJ, Mills GM, et al. Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2015;24:913-20. [PMID: 25800242] doi:10.1158/1055-9965.EPI-14-1321
10. Imperiale TF, Ransohoff DF, Itzkowitz SH, Levin TR, Lavin P, Lidgard GP, et al. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;370:1287-97. [PMID: 24645800] doi:10.1056/NEJMoa1311194